首页> 外文期刊>Journal of vector borne diseases >Small-scale (Phase II) evaluation of the efficacy and residual activity of SumiShield (R) 50 WG (clothianidin 50%, w/w) for indoor residual spraying in comparison to deltamethrin, bendiocarb and pirimiphos-methyl for malaria vector control in Karnataka state, India
【24h】

Small-scale (Phase II) evaluation of the efficacy and residual activity of SumiShield (R) 50 WG (clothianidin 50%, w/w) for indoor residual spraying in comparison to deltamethrin, bendiocarb and pirimiphos-methyl for malaria vector control in Karnataka state, India

机译:小规模(II期)与达美沙林,前芬菊酯,肺炎和Pirimiphos-甲基在卡纳塔克邦的疟原虫血虫蛋白,疟原虫和吡米哌啶甲基相比,评价Sumishield(R)50 Wg(粉型50%,W / W)的疗效和残留活性 国家,印度

获取原文
获取原文并翻译 | 示例
           

摘要

Background & objectives: There is an urgent need of introducing new insecticide molecules with novel modes of action to counter the ever growing insecticide-resistance in mosquito vectors. In the present study, a new insecticide molecule, SumiShield 50 WG (clothianidin 50%, w/w) was investigated for its efficacy as an indoor residual spray along with its residual action in comparison to deltamethrin, pirimiphos-methyl and bendiocarb.
机译:背景和目标:迫切需要用新颖的作用方式引入新的杀虫剂分子,以抵消蚊子载体中不断增长的杀虫剂抵抗力。 在本研究中,研究了一种新的杀虫剂分子,Sumhikield 50Wg(CloteNidin 50%,W / W),其效果作为室内残留喷雾以及其残留作用与溴氰菊酯,Pirimiphos-甲基和BendioCarb相比。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号